Status:
COMPLETED
Home Telemonitoring In Patients After Myocardial Infarction
Lead Sponsor:
Mayo Clinic
Conditions:
Myocardial Infarction
Heart Attack
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being done to determine if taking an electrocardiogram (ECG) by a portable device (SmartHeart) followed by a phone call will improve patient outcomes by early recognition of abnormalitie...
Eligibility Criteria
Inclusion
- Acute myocardial infarction, both STEMI and non-STEMI.
- Able to use the home ECG telemonitoring.
- Must have smartphone device with home wi-fi/mobile internet which allows for 24/7 ability to transmit ECG.
- Caring family member who will be able to help/perform the ECG in case the patient won't be able to do it.
Exclusion
- No ability to use the device at home/unable to comply with the device instructions
- No smartphone device or home wi-fi/mobile internet which prevent 24/7 ability to transmit ECG
- Cannot download the smartheart app
- No support in home environment
- Out of hospital cardiac arrest: secondary to a non-shockable rhythm, unrelated to an acute coronary syndrome, or with any level of neurologic damage.
- Resident of nursing home or acute care facility
- Uninterpretable ECG at discharge - left bundle branch block (LBBB), pacemaker or implantable cardioverter defibrillator (ICD) with pacing dependence.
- Patients who are planned for staged PCI after the index hospitalization
Key Trial Info
Start Date :
October 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2024
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT04664881
Start Date
October 14 2020
End Date
May 2 2024
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905